The Overexpression of P53 Frequency in Epithelial Ovarian Cancer
Objective: To determine the frequency of P53 overexpression in epithelial ovarian cancer.
Methodology: The cross-sectional study was conducted at the Department of Pathology, KRL Hospital Islamabad, from April 2018 to October 2019. Ninty four biopsy specimens using Non-probability consecutive sampling technique from the gynaecology department patients aged between 25-65 years, Biopsies and resected specimens of all adult females diagnosed by histopathologist as epithelial ovarian cancer was chosen. Immunohistochemical processing was performed using a Dako M7007 Kits were used applying FISH method. Results were interpreted by the consultant pathologist for overexpression (positive/negative) of p53. All this data was recorded on a predesigned proforma.
Results: An average of 47.00 years and a standard deviation of 10.80 years were found among the participants in this study. On average, the illness persisted for 5.79 2.00 months, with a mean. age of 46. Ovarian cancer was found in 12.77% of the patients (n = 12). In 34 (36.17%) of the cases of epithelial ovarian cancer, p53 overexpression was found.
Conclusion: Epithelial ovarian cancer has had a high prevalence of P53 overexpression. Immunostaining of p53 in epithelial ovarian cancer may improve overall health and reduce mortality and morbidity for the general population.
Copyright (c) 2022 Journal of The Society of Obstetricians and Gynaecologists of Pakistan
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.